Kraig Biocraft Laboratories announced that it has secured usage rights to a substantial block of government‑owned mulberry gardens located near its Southeast Asian sericulture facilities. The agreement gives the company a reliable source of high‑quality mulberry leaf, the essential feedstock for its genetically engineered silkworms that produce recombinant spider‑silk fibers.
By gaining direct control over the mulberry supply chain, Kraig Biocraft aims to reduce dependence on external suppliers and improve logistics for its scaled‑up manufacturing pipeline. The move is intended to support the company’s ongoing production expansion of its BAM‑1 Alpha hybrid spider‑silk yarns, which are targeted for performance textiles, technical apparel and luxury fashion markets.
CEO Kim Thompson said the acquisition “marks another critical step in building an integrated and resilient production ecosystem for our spider‑silk technologies. Securing direct access to high‑quality mulberry acreage gives us greater control over our supply chain and positions us to accelerate production of our BAM‑1 Alpha hybrid spider silk.”
The new land‑use rights are expected to enable Kraig Biocraft to meet its goal of delivering commercial shipments to major global brands in the second half of 2025. By securing a stable, strategically positioned source of leaf material, the company can better align production capacity with anticipated demand and move closer to generating revenue from its spider‑silk products.
Kraig Biocraft has already expanded its production footprint with multiple rearing centers in Southeast Asia and has been hiring aggressively to support this growth. The company’s sericulture expert, Dr. Nirmal Kumar, continues to guide the optimization of silkworm breeding and feedstock management, reinforcing the technical foundation of the expansion.
Overall, the acquisition of government‑owned mulberry gardens strengthens Kraig Biocraft’s competitive position, reduces supply‑chain risk, and accelerates the company’s path to commercial viability in the emerging spider‑silk market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.